Compare Liquidia Corporation Common Stock (LQDA) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Lufax Holding Ltd — how do they compare? Liquidia Corporation Common Stock trades at $34.9 (market cap $2.40B), while Lufax Holding Ltd trades at $0.85 (market cap $894.58M). The key difference: Liquidia Corporation Common Stock is far larger — about 2.7× Lufax Holding Ltd's market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Lufax Holding Ltd for 14 Days on average.
| LQDA | LU | |
|---|---|---|
Market Cap | $2.40B | $894.58M |
Volume | 2,857,547 | 1,044,976 |
Sector | Health | Financials |
52-Week High | $91.03 | $3.64 |
52-Week Low | $22.02 | $0.86 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $2.30B | $58.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lufax Holding Ltd (LU) trades at $0.9201, down 0.47% on the day, reflecting ongoing challenges in China's consumer lending market. The stock shows a bearish technical signal with negative earnings trends, having missed EPS estimates for three consecutive quarters. Recent corporate actions include a 10:1 reverse stock split effective October 2026. Despite deep value metrics (P/S 0.24, P/B 0.07), the company reports negative net income margins and declining revenue, with 2025 showing a $2.10B loss on $23.11B revenue.
LU presents a high-risk opportunity with significant analyst divergence. While 69% of analysts rate it Buy citing deep valuation and Ping An backing, fundamental deterioration and regulatory headwinds create substantial downside risk. The stock's appeal rests on potential capital return catalysts rather than business turnaround, requiring careful risk assessment given China's tightening financial regulations and persistent operational losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
